US Patent Issued to Microvascular Therapeutics, LLC
Microvascular Therapeutics (MVT) has been awarded US Patent Number 10,279,053, entitled, “Microbubble Compositions, Methods of Making Same and Method of Using Same,” issued on May 7th, 2019. - May 30, 2019
Microvascular Therapeutics Licenses Patents from Stanford University
Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, has licensed two patent applications from Stanford University to support the development for detection of pancreatic cancer. - April 16, 2019
MicroVascular Therapeutics Licenses Patent from Triangle Biotechnology Inc.
MicroVascular Therapeutics (MVT), LLC, a privately-held Tucson-based biotechnology company, has licensed a patent from Triangle Biotechnology, Inc, entitled, "Formulation of acoustically activatable particles having low vaporization energy and methods for using same" (U.S. Patent No. 9,427,410, issued August 30th, 2016). - July 11, 2018
Microvascular Therapeutics Receives $1.6M Grant from National Heart, Lung, and Blood Institute of the National Institutes of Health
Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.6M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Jennifer Marshall, CFO of MVT, said, “This grant will enable us to develop a... - April 16, 2018